Skip to main content

Day: June 2, 2022

Procaps Group Reports Preliminary First Quarter 2022 Results

Net Revenues Increased by 11% to U$ 86 million, with Adjusted EBITDA Up 15% Year-Over-Year to $9 Million MIAMI and BARRANQUILLA, Colombia, June 02, 2022 (GLOBE NEWSWIRE) — Procaps Group S.A. (NASDAQ: PROC) (“Procaps”), a leading integrated LatAm healthcare and pharmaceutical conglomerate, today announced its preliminary financial results for the quarter ended March 31, 2022 (“Q1-22”). Preliminary Q1-22 Results HighlightsNet revenues for Q1-22 totaled $86 million, an increase of 11% when compared with the quarter ended March 31, 2021 (“Q1-21”), primarily driven by strong demand across Procaps Colombia, CAN and CASAND, as well as from our continued rollout of new product launches. Adjusted EBITDA increased by 15% to $9 million for Q1-22, with an Adjusted EBITDA margin of 11% for the quarter.   Q122 Q121 Δ%Net Revenues 86...

Continue reading

Cerberus Sentinel completes acquisition of Creatrix, Inc.

U.S. cybersecurity services firm expands security and identity management services with woman-owned business Scottsdale, Ariz., June 02, 2022 (GLOBE NEWSWIRE) — via Investor Wire — Cerberus Cyber Sentinel Corporation (NASDAQ: CISO), a cybersecurity consulting and managed services firm based in Scottsdale, Ariz., announced that it has completed the acquisition of Creatrix, Inc., a woman-owned cybersecurity and information technology company based in Tennessee and Maryland. Under the terms of the agreement, Creatrix will become a wholly owned subsidiary of Cerberus Sentinel. The company was co-founded by Anna Fleeman, founder and managing director, and Sami Elhini, co-founder and president. Creatrix is recognized for its expertise in identity management as well as systems integration and software engineering, and it specializes...

Continue reading

Arbutus to Participate in June Investor Conferences

WARMINSTER, Pa., June 02, 2022 (GLOBE NEWSWIRE) — Arbutus Biopharma Corporation (Nasdaq: ABUS), a clinical-stage biopharmaceutical company leveraging its extensive virology expertise to develop novel therapeutics that target specific viral diseases, today announced that the Company will participate in the following upcoming investor conferences taking place in New York: Jefferies Healthcare Conference (June 8 – 10, 2022)Fireside Chat: 3:00 pm ET on Thursday, June 9, 2022 Presenters: Michael McElhaugh, Chief Business Officer; Dr. Gaston Picchio, Chief Development Officer; and David Hastings, Chief Financial OfficerJMP Securities Life Sciences Conference (June 15 – 16, 2022)Fireside Chat: 9:00 am ET on Wednesday, June 15, 2022 Presenters: Michael McElhaugh, Chief Business Officer; Dr. Michael Sofia; Dr. Gaston Picchio,...

Continue reading

DMG Blockchain Solutions Posts Q2 Revenue of $11.9M, up 377% Year Over Year, and Announces Quarterly Financial Results and Corporate Update on June 3, 2022

Conference Call to Review Results to be Held June 3, 2022 at 4:05 PM ET VANCOUVER, British Columbia, June 02, 2022 (GLOBE NEWSWIRE) — DMG Blockchain Solutions Inc. (TSX-V: DMGI) (DMGGF:OTC US) (FRANKFURT:6AX) (“DMG” or the “Company”), a vertically integrated blockchain and cryptocurrency technology company, is pleased to report its Q2 2022 filings for the quarter ended March 31, 2022 (all financial references are in Canadian Dollars unless specified otherwise). The Company will also hold a corporate update conference call on June 3, 2022 at 4:05 PM ET. Highlights:Increased quarterly revenues to $11.9M, up 377% from same period a year ago Increased EPS to $0.03 per share for six months ending March 31, up from (0.01) loss per share for the same period a year ago 372 BTC held as of March 31, 2022 Strong balance sheet with $125M...

Continue reading

Radisson Blu Hotel, Nice celebrates 25th anniversary with new summer rooftop pop-up restaurant, Calade by Julia Sedefdjian, France’s youngest Michelin-star chef

Julia Sedefdjian & David Rodriguez at Calade rooftop restaurant at Radisson Blu Hotel Nice Julia Sedefdjian & David Rodriguez at Calade rooftop restaurant at Radisson Blu Hotel NiceJulia Sedefdjian & David Rodriguez at Calade rooftop Julia Sedefdjian & David Rodriguez at Calade rooftopCalade by Julia Sedefdjian Calade by Julia SedefdjianMain course of octopus at Calade Main course of octopus at CaladeJulia Sedefdjian with ingredients for new menu at Calade rooftop Julia Sedefdjian with ingredients for new menu at Calade rooftopJulia Sedefdjian & David Rodriguez at Calade restaurant Julia Sedefdjian & David Rodriguez at Calade restaurantChef of Calade at Radisson Blu Hotel Nice – David Rodriguez Portrait Chef of Calade at Radisson Blu Hotel Nice – David Rodriguez PortraitStarter...

Continue reading

White Gold Corp. Announces Webinar to Provide Overview of its Fully Funded $6 Million 2022 Exploration Program & Corporate Update

TORONTO, June 02, 2022 (GLOBE NEWSWIRE) — White Gold Corp. (TSX.V: WGO, OTCQX: WHGOF, FRA: 29W) (the “Company”) is pleased to announce that the Company will be hosting a Webinar on Tuesday, June 7th, 2022. Join CEO, David D’Onofrio; Co-founder & Chief Technical Advisor, Shawn Ryan and VP Exploration, Terry Brace, as they provide an overview of the 2022 exploration program on its district scale 350,000 hectare land package, representing over 40% of the prolific White Gold District in Yukon, Canada. The 2022 program is designed to be focused and impactful and further evaluate recent discoveries on the Betty and White Gold properties. Maiden drill testing will also be performed on several other new targets. A significant early-stage regional exploration program is also planned to identify and advance other targets...

Continue reading

Clearmind Medicine and SciSparc Collaboration Yields Another Patent Application for Cocaine Addiction Treatment

No dedicated treatment currently available for cocaine addiction VANCOUVER, June 02, 2022 (GLOBE NEWSWIRE) — Clearmind Medicine Inc. (CSE: CMND, OTC Pink: CMNDF, FSE: CWY0) (“Clearmind” or the “company“), a biotech company focused on discovery and development of novel psychedelic-derived therapeutics to solve major undertreated health problems, today announced it has filed a provisional patent application related to cocaine addiction.The move results from the company’s recently launched collaboration with SciSparc Ltd. (NASDAQ: SPRC), a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders of the central nervous system (“SciSparc“). The patent application refers to the proprietary combination of Clearmind’s MEAI, a novel proprietary psychedelic...

Continue reading

Real Brands Signs Letter of Intent to Acquire Assets of Boulder Botanical

Boulder Botanical exterior Real Brands has entered an LOI to acquire Boulder Botanical’s assets in Golden, Colorado., with the intent to continue Boulder’s current CBD and non-CBD manufacturing and distribution business that serves major distribution channels nationwide.North Providence, RI, and Golden, CO, June 02, 2022 (GLOBE NEWSWIRE) — Real Brands Inc. (OTCQB: RLBD) announced today that it has signed a letter of intent (LOI) to acquire substantially all the assets of Boulder Botanicals & Biosciences Laboratories, Inc. (Boulder Botanical), a manufacturer of white-label and private-label CBD and non-CBD products. The acquisition will include Boulder Botanical’s brands, IP, distribution and 27,000 sq. ft. R&D and production facility in Golden, Colorado. On April 22, 2022, Boulder Botanical became a subsidiary of Frankens...

Continue reading

Guardforce AI Announces LOI to Acquire Twelve Additional Robotics Companies in China

NEW YORK, NY, June 02, 2022 (GLOBE NEWSWIRE) — Guardforce AI Co., Limited (“Guardforce AI” or the “Company”) (NASDAQ:GFAI, GFAIW), an integrated security solutions provider, announced today it has signed a supplemental letter of intent (LOI) with Shenzhen Kewei Robot Technology Co., Limited (“Kewei”) to acquire an additional twelve robotics companies, which follows the Company’s previously announced definitive agreement to acquire seven robotics companies in China. The twelve robotics companies are among the leading providers of Robotics-as-a-Service (RaaS) solutions within their respective markets in China and bring established customers and management teams. The 12 companies are located in key economic areas across northeast, northwest, central and southwest China. Most of the provinces served are among the top 20...

Continue reading

Genetron Health Reports Unaudited First Quarter 2022 Financial Results

BEIJING, June 02, 2022 (GLOBE NEWSWIRE) — Genetron Holdings Limited (“Genetron Health” or the “Company”, NASDAQ: GTH), a leading precision oncology platform company in China that specializes in offering molecular profiling tests, early cancer screening products and companion diagnostics development, today reported its unaudited financial results for the first quarter ended March 31, 2022. First Quarter and Recent HighlightsRecorded total revenue of RMB 110.3 million (US $17.4 million) in the first quarter of 2022, representing 19.8% increase over the same period in 2021.LDT revenue was RMB 81.5 million (US $12.9 million), representing 13.5% increase over the same period in 2021. IVD revenue was RMB 18.0 million (US $2.8 million), representing 18.1% growth year-over-year. Development services revenue was RMB 10.8 million (US...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.